The mission of Roswell Park Cancer Institute (RPCI) CCSG Administration is to foster research, collaboration, and scientific productivity of CCSG members. During the award period, staff members have supported: 1) achieving a 17% increase in peer-reviewed, cancer grant funding;2) adding 3 new shared resources and consolidation of two existing Shared Resource services;3) adding 137 new clinical and research faculty (including 51 new CCSG members);4) planning for a new 142,000 square foot (sf) clinical, research, and office building;5) awarding more than $9.5 million in CCSG and RPCI developmental research funds;6) supporting planning and evaluation activities for the research programs. Shared Resources, and other initiatives;7) implementing more rigorous CCSG membership criteria which led to increased focus with reduced membership from 149 in 2008 to 138;8) implementing Laboratory Information Management Systems in five Shared Resources;9) developing new electronic research tools to foster grant development;and 10) implementing an Inclusion Council to foster collaboration and coordination among outreach efforts, research programs, and Shared Resources. Administration supports the Director in new faculty recruitment;administrative leadership of the planning and evaluation process;administrative oversight of Research Programs and shared resources;development and management of computer databases and other information systems tools;fiscal management and consultation;space and equipment management;providing support for selection, award, and monitoring of pilot research funding;administration of the membership and review process;coordination of research seminars, workshops, and retreats;leadership or assistance in developing collaborations between and among investigators for new research initiatives;planning, coordination, and execution of multi-project research grants (e.g., SPOREs, PPGs);and targeted communication of cancer-related funding opportunities and research tools to CCSG members. Administration includes 4.5 FTE within the CCSG administrative unit, which is leveraged by an additional 27 FTE of administrative and information technology support staff. Administration makes up 1.4% of the total RPCI research budget and 5.6% of the requested CCSG budget.

Public Health Relevance

RPCI Administration manages and facilitates the research of the only NCI Comprehensive Cancer Center in upstate New York, with the goal to foster cutting edge, transdisciplinary science to understand, prevent, and cure cancer. RPCI Administration supports six research programs, 14 shared resources, membership, planning evaluation, and research development activities.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016056-37
Application #
8738381
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-06-16
Project End
2019-04-30
Budget Start
2014-06-26
Budget End
2015-04-30
Support Year
37
Fiscal Year
2014
Total Cost
$218,391
Indirect Cost
$86,382
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
824771034
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Lu, Yingchang; Beeghly-Fadiel, Alicia; Wu, Lang et al. (2018) A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res 78:5419-5430
Terakawa, Tomoaki; Katsuta, Eriko; Yan, Li et al. (2018) High expression of SLCO2B1 is associated with prostate cancer recurrence after radical prostatectomy. Oncotarget 9:14207-14218
Zhu, Qianqian; Yan, Li; Liu, Qian et al. (2018) Exome chip analyses identify genes affecting mortality after HLA-matched unrelated-donor blood and marrow transplantation. Blood 131:2490-2499
Visioni, Anthony; Kim, Minhyung; Wilfong, Chandler et al. (2018) Intra-arterial Versus Intravenous Adoptive Cell Therapy in a Mouse Tumor Model. J Immunother 41:313-318
Li, Yanchun; Opyrchal, Mateusz; Yao, Song et al. (2018) The role of programmed death ligand-1 and tumor-infiltrating lymphocytes in breast cancer overexpressing HER2 gene. Breast Cancer Res Treat 170:293-302
Mastri, Michalis; Lee, Christina R; Tracz, Amanda et al. (2018) Tumor-Independent Host Secretomes Induced By Angiogenesis and Immune-Checkpoint Inhibitors. Mol Cancer Ther 17:1602-1612
Dong, Jing; Levine, David M; Buas, Matthew F et al. (2018) Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus. Clin Gastroenterol Hepatol 16:1598-1606.e4
Sass, Stephanie N; Ramsey, Kimberley D; Egan, Shawn M et al. (2018) Tumor-associated myeloid cells promote tumorigenesis of non-tumorigenic human and murine prostatic epithelial cell lines. Cancer Immunol Immunother 67:873-883
Neubauer, Bjoern; Schrankl, Julia; Steppan, Dominik et al. (2018) Angiotensin II Short-Loop Feedback: Is There a Role of Ang II for the Regulation of the Renin System In Vivo? Hypertension 71:1075-1082
Goodrich, Maxwell M; Talhouk, Ramzi; Zhang, Xiaojing et al. (2018) An approach for controlling the timing and order of engineered mutations in mice. Genesis 56:e23243

Showing the most recent 10 out of 1555 publications